227 related articles for article (PubMed ID: 9224398)
21. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
Xia G; Truitt RL; Johnson BD
Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
[TBL] [Abstract][Full Text] [Related]
22. Prevention of chronic rejection and graft arteriosclerosis by tolerance induction.
Orloff MS; DeMara EM; Coppage ML; Leong N; Fallon MA; Sickel J; Zuo XJ; Prehn J; Jordan SC
Transplantation; 1995 Jan; 59(2):282-8. PubMed ID: 7839452
[TBL] [Abstract][Full Text] [Related]
23. Split tolerance in spleen chimeras.
Sprent J; Hurd M; Schaefer M; Heath W
J Immunol; 1995 Feb; 154(3):1198-206. PubMed ID: 7822792
[TBL] [Abstract][Full Text] [Related]
24. Small intestine transplantation in the rat--immunology and function.
Kirkman RL; Lear PA; Madara JL; Tilney NL
Surgery; 1984 Aug; 96(2):280-7. PubMed ID: 6611597
[TBL] [Abstract][Full Text] [Related]
25. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.
Pelot MR; Pearson DA; Swenson K; Zhao G; Sachs J; Yang YG; Sykes M
Biol Blood Marrow Transplant; 1999; 5(3):133-43. PubMed ID: 10392959
[TBL] [Abstract][Full Text] [Related]
26. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells.
Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N
Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518
[TBL] [Abstract][Full Text] [Related]
27. Vascularized lymph node transplantation induces graft-versus-host disease in chimeric hosts.
Francois CG; Brouha PC; Laurentin-Perez LA; Perez-Abadia G; Grossi FV; Barker JH; Hewitt CW; Kon M; Ramsamooj R; Maldonado C
Transplantation; 2006 May; 81(10):1435-41. PubMed ID: 16732182
[TBL] [Abstract][Full Text] [Related]
28. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
29. Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers.
Foster RD; Ascher NL; McCalmont TH; Neipp M; Anthony JP; Mathes SJ
Transplantation; 2001 Sep; 72(5):791-7. PubMed ID: 11571439
[TBL] [Abstract][Full Text] [Related]
30. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
[TBL] [Abstract][Full Text] [Related]
31. Significant MLR but not CTL responses against recipient antigens generated in T cells from bone marrow chimeras recovered from acute GVHD.
Morohashi T; Ogasawara K; Kitaichi N; Iwabuchi K; Onoé K
Bone Marrow Transplant; 2000 Nov; 26(10):1069-76. PubMed ID: 11108305
[TBL] [Abstract][Full Text] [Related]
32. Induction of oral tolerance in bone marrow transplantation recipients suppresses graft-versus-host disease in a semiallogeneic mouse model.
Nagler A; Ohana M; Alper R; Doviner V; Sherman Y; Rabbani E; Engelhardt D; Ilan Y
Bone Marrow Transplant; 2003 Aug; 32(4):363-9. PubMed ID: 12900772
[TBL] [Abstract][Full Text] [Related]
33. Sirolimus promotes tolerance for donor and recipient antigens after MHC class II disparate bone marrow transplantation in rats.
Jäger MD; Liu JY; Timrott KF; Popp FC; Stoeltzing O; Lang SA; Piso P; Geissler EK; Schlitt HJ; Dahlke MH
Exp Hematol; 2007 Jan; 35(1):164-70. PubMed ID: 17198885
[TBL] [Abstract][Full Text] [Related]
34. Subclinical GvHD in non-irradiated F1 hybrids: severe lymphoid-tissue GvHD causing prolonged immune dysfunction.
Sprangers B; Van Wijmeersch B; Luyckx A; Sagaert X; Verbinnen B; Rutgeerts O; Lenaerts C; Tousseyn T; Dubois B; Waer M; Billiau AD
Bone Marrow Transplant; 2011 Apr; 46(4):586-96. PubMed ID: 20603621
[TBL] [Abstract][Full Text] [Related]
35. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
[TBL] [Abstract][Full Text] [Related]
36. Induction of stable chimerism and transplantation tolerance to rat islet and heart allografts by ultraviolet-B modulation of bone marrow cells.
Jin MX; Engelstad K; Oluwole SF
Transplantation; 1992 Jul; 54(1):113-8. PubMed ID: 1385914
[TBL] [Abstract][Full Text] [Related]
37. Gut mucosal mast cells and goblet cells during acute graft-versus-host disease in rats.
Levy DA; Wefald A
Ann Inst Pasteur Immunol; 1986; 137D(2):281-8. PubMed ID: 3541968
[TBL] [Abstract][Full Text] [Related]
38. Alloreactive CD4 T lymphocytes responsible for acute and chronic graft-versus-host disease are contained within the CD45RChigh but not the CD45RClow subset.
Xystrakis E; Bernard I; Dejean AS; Alsaati T; Druet P; Saoudi A
Eur J Immunol; 2004 Feb; 34(2):408-17. PubMed ID: 14768045
[TBL] [Abstract][Full Text] [Related]
39. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
40. PGG-glucan, a leukocyte-specific immunostimulant, does not potentiate GVHD or allograft rejection.
Washburn WK; Otsu I; Gottschalk R; Monaco AP
J Surg Res; 1996 May; 62(2):179-83. PubMed ID: 8632636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
